Pearson Mark 4
4 · Equitable Holdings, Inc. · Filed Apr 17, 2026
Research Summary
AI-generated summary of this filing
Equitable CEO Mark Pearson Exercises Options, Sells Shares
What Happened
- Mark Pearson, President & CEO and a director of Equitable Holdings (EQH), exercised 1,387 stock options and immediately sold those 1,387 shares on April 15, 2026. The reported exercise cost was $23.18 per share (total $32,151) and the shares were sold at a weighted-average price of $40.03 for total proceeds of $55,518. The filing shows the exercised derivative was converted into shares and then disposed of (a cashless-style exercise + sale).
Key Details
- Transaction date: April 15, 2026; Form 4 filed April 17, 2026 (appears timely).
- Exercise detail: 1,387 shares exercised at $23.18 each (total exercise cost $32,151).
- Sale detail: 1,387 shares sold in multiple trades at prices ranging $40.00–$40.06; weighted-average $40.03; total proceeds $55,518. Reporting person can provide trade-level prices on request (footnote).
- Net cash from the sequence (proceeds minus exercise cost) ≈ $23,367 before taxes/fees.
- Holdings after transaction: not specified in the summary table of your prompt; footnote F2 notes holdings include Restricted Stock Units and 11,011 shares from the Employee Stock Purchase Plan.
- Footnotes: F1 — trades were executed under a Rule 10b5-1 trading plan adopted May 16, 2025. F3 — sale executed in multiple trades (price range above). F4 — options were granted under the 2019 Omnibus Incentive Plan and vested in installments beginning Feb 26, 2021.
Context
- This was an exercise of options followed by an immediate sale of the resulting shares (commonly called a cashless exercise or sell-to-cover sequence), which converts option value into cash rather than increasing the insider's share stake. Such sales under a pre-existing 10b5-1 plan are typically automated and not necessarily a timing signal about the CEO’s view of the stock.
Insider Transaction Report
Form 4
Pearson Mark
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
[F1][F2]2026-04-15$23.18/sh+1,387$32,151→ 803,070.298 total - Sale
Common Stock
[F1][F3][F2]2026-04-15$40.03/sh−1,387$55,518→ 801,683.298 total - Exercise/Conversion
Employee Stock Option (right to buy)
[F1][F4]2026-04-15−1,387→ 108,800 totalExercise: $23.18Exp: 2030-02-26→ Common Stock (1,387 underlying)
Footnotes (4)
- [F1]The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2025.
- [F2]Includes Restricted Stock Units and 11,011 shares acquired under the Employee Stock Purchase Plan.
- [F3]This transaction was executed in multiple trades at prices ranging from $40.0000 to $40.0600. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.
- [F4]Grant of employee stock option under the Issuer's 2019 Omnibus Incentive Plan exempt under Rule 16b-3. The options vested in three installments beginning on February 26, 2021.
Signature
/s/ Stella Lee as attorney-in-fact for Mark Pearson|2026-04-16